The Intravitreal Autologous Platelet Concentrate Injection as an Adjunct of Vitrectomy for the Treatment of Refractory Macular Holes

Clinical trial NCT02081170 · UNKNOWN

Trial details

NCT number: NCT02081170
Sponsor: Samsung Medical Center
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Macular Hole With High Myopia (Spherical Equivalent ≤ -6.0 Diopters) or,Large Size Macular Hole (Diameter > 600 Microns) or Recurred or Failed Macular Hole From Previous Surgery or Chronic Macular Hole (Symptom Duration > 6 Months)

Start date: 2013-12-01
Primary completion: 2014-12-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.